Navigation Links
Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
Date:6/18/2008

Case is first to show safety and effectiveness of using cloned cells alone

to kill tumors

SEATTLE, June 18 /PRNewswire/ -- Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, reports these findings in the June 19 issue of the New England Journal of Medicine.

Yee and colleagues removed CD4+ T cells, a type of white blood cell, from a 52-year-old man whose Stage 4 melanoma had spread to a groin lymph node and to a lung. T cells specific to targeting the melanoma were then expanded vastly in the laboratory using modifications to existing methods. The lab-grown cells were then infused into the patient with no additional pre- or post-conditioning therapies, such as growth-factor or cytokine treatment. Two months later, PET and CT scans revealed no tumors. The patient remained disease free two years later, when he was last checked.

"We were surprised by the anti-tumor effect of these CD4 T cells and its duration of response," Yee said. "For this patient we were successful, but we would need to confirm the effectiveness of therapy in a larger study."

Yee cautioned that these results, presented in the journal's "Brief Report" section, represent only one patient with a specific type of immune system whose tumor cells expressed a specific antigen. More studies are needed to confirm the effectiveness of the experimental T cell therapy. If proven successful in more patients, Yee predicted this therapy could be used for the 25 percent of all late-stage melanoma patients who have the same immune-system type and tumor antigen.

Using a patient's own immune system to combat cancer, called immunotherapy, is a growing area of research that aims to develop
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... HILLS, Calif. , May 24, 2013 /PRNewswire-iReach/ -- ... state,s leading non-profit substance abuse services organization, is hosting ... the Beverly Hills Hotel on June 6, 2013.  More ... to raise funds for the adolescent residential treatment centers, ... well as honor individuals whose accomplishments have positive influences ...
(Date:5/24/2013)... -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today ... Bank Health Care Conference to be held May 29-30 ... Adrian Adams , Chief Executive Officer and President, ... and its product pipeline at 12:00 p.m. ET on ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also be ...
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 43SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... 1 Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: ... University to be presented by Howard Safran, M.D., head ... oral session at the Annual Meeting of the International ... with cancer of the lower esophagus demonstrated a high ...
... Baxa Corporation announces the launch of a new ... Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program ... they need to ensure that each dose dispensed is ... one-time setup fees or signing capital leases. , "Our ...
Cached Medicine Technology:OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 2OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 4OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 5Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R) 2Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R) 3
(Date:5/24/2013)... 24, 2013 Range Kleen Mfg. strives to ... the Customer, from the President's desk to the Shipping Dock.” ... and integrity, and having passion while creating excellence and quality ... a company to do the right thing and what better ... those affected by devastation. , Throughout the year Range Kleen ...
(Date:5/24/2013)... Alan Mozes HealthDay Reporter , , FRIDAY, May ... Lewis, accomplishments are remarkable. But it was a physical ... the top of her sport. "I was an ... when my scoliosis was diagnosed by my orthopedic surgeon," ... the Scoliosis Research Society and the American Academy of ...
(Date:5/24/2013)... 24, 2013 With Memorial Day Weekend upon ... Insurance is offering tips to help prevent grill fires ... Protection Association (NFPA) reports that gas grills led to ... Charcoal or other solid-fueled grills, meanwhile, caused approximately 1,200 home ... result, Amica Insurance is sharing the following tips from the ...
(Date:5/24/2013)... OR (PRWEB) May 24, 2013 ... Sustainable Cards, major competitors in sustainable card material, ... of using forest materials as a sustainable gift ... is to identify industry challenges and increase education ... card programs to support the reduction of carbon ...
(Date:5/24/2013)... Area homeowners dreaming about owning a hot tub will ... from at factory-direct pricing during the Jacuzzi Hot Tubs ... at Emerald Pool and Patio in Bend, May ... leading hot tub brand, scheduled the event as part of ... feature popular hot tub models at up to 50% savings ...
Breaking Medicine News(10 mins):Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... Hospitals with more expertise handling these attacks also ... News) -- Brain hemorrhage patients have better outcomes ... handle many brain attack emergencies, according to updated ... Subarachnoid hemorrhage (SAH) occurs when a blood vessel ...
... RMD ), announced today that on Thursday, February 5, 2009, it ... 2009, ended December 31, 2008. ResMed will issue an earnings press ... call to review its quarterly results, market trends, and future outlook. ... begin at 1:30 p.m. Pacific Time and will be webcast on ...
... Jan. 22 This is a sad day for the ... should be led from the bottom up, rather than the ... decision are predictable. It also is predictable that Hearing ... by SEIU President Andy Stern to conduct the hearing would ...
... ST. PAUL, Minn., Jan. 22 Project 515 is proposing,legislation to ... severe health issues and the death of a loved one. , ... Capitol news conference,today, will provide committed same-sex couples the same right ... final wishes of their partners, -- Preserve their ...
... patients, families , , THURSDAY, Jan. 22 (HealthDay News) -- ... discussion when physicians talk to patients about serious medical ... The study, published in the January issue of ... , said nurses play a critical role with the ...
... maxim "location, location, location" also plays a role in ... behavior of other people. , University of Washington psychologists ... and understanding of familiar actions by a person to ... by the location in which the new action is ...
Cached Medicine News:Health News:New Brain Hemorrhage Guidelines Stress Quick Action 2Health News:ResMed to Webcast Second Quarter 2009 Earnings Conference Call 2Health News:Statement by UHW on SEIU's Claims Regarding SEIU-Trusteeship Hearing Process Chaired by Ray Marshall 2Health News:Project 515 Proposes Legislation to Ensure Equality During Times of Illness and Death 2Health News:Project 515 Proposes Legislation to Ensure Equality During Times of Illness and Death 3Health News:Nurses Often Left Out of Medical Error Talks 2Health News:Infants draw on past to interpret present, understand other people's behavior 2Health News:Infants draw on past to interpret present, understand other people's behavior 3
Stryker Instruments, the leader in surgical helmets, offers its 4th generation of personal protection systems for todays surgical environment the Sterishield T4 System....
... The PS Medical Delta valve is ... fluid (CSF) and maintain intraventricular pressure ... regardless of patient position. The normally ... response to positive ventricular pressure. Working ...
... PS Medical Strata valve is an adjustable ... properties of the valve can be changed ... to minimize overdrainage of cerebrospinal fluid (CSF) ... normal physiologic range, regardless of patient position. ...
...
Medicine Products: